Quality of Life Studies in Chemotherapy-Induced Emesis

Oncology (Switzerland)

Volumn 53, Issue 1, 1996, Pages 92-95

  Osoba, David ^a   Zee, Benny ^b   Warr, David ^c   Kaizer, Leonard ^d   Latreille, Jean ^e   Pater, Joseph ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Canada   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d CREDIT VALLEY HOSPITAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Emesis; Prognostic factors; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ANOREXIA; CANCER CHEMOTHERAPY; COGNITION; CONFERENCE PAPER; DRUG INDUCED DISEASE; DYSPNEA; FATIGUE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; VOMITING;

EID: 0029835209     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227647     Document Type: Article

References (14)

1. Morrow GR, Black PM: Anticipatory nausea and vomiting side effects experienced by cancer patients undergoing chemotherapy treatment; in Osoba D (ed): Effect of Cancer on Quality of Life, Boca Raton, CRS Press, 1991, pp 251-268.
2. Coates A, Abraham S, Kaye S, Sowerbutts T, Frewin C, Fox RM, Tattcrsall, MHN: On the receiving end-patient perception of the sidc-effects of cancer chemotherapy, Eur J Cancer Clin Oncol 1983;1:203-208.
3. Lindley CM, Bernard S, Fields SM: Incidence and duration of chemotherapy induced nausea and vomiting in the outpatient oncology population, J Clin Oncol 1989:7:1142-1149.
4. Laszlo J: Nausea and vomiting as major complications of canccr chemotherapy, Drugs 1983:25:1-7.
5. Levine AM, Richardson JL, Marks G, Chan K, Graham J, Sclscr JN, Kishbaugh C, Shelton DR, Johnson CA: Compliance with oral drug therapy in patients with hematologic malignancy, J Clin Oncol 1987;5:1469-1476.
6. Richardson JL, Snorks G, Levine A: The influence of symptoms of disease and side effects of treatment on compliance with therapy, J Clin Oncol 1988;6:1746-1752.
7. Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Ostcrhaus JT: Quality of life consequences of chemotherapy-induced cmc-sis, Qual Life Res 1992;1:331-340.
8. O'Brien BJ, Rusthovcn J, Rocchi A, Lafreillc J, Fine S, Vandenbcrg T, Laberge F: Impact of chemotherapy-associated nausea and vomiting on patients’ functional status and costs: Survey of five Canadian centres, Can Med Assoc J 1993;149:296-302.
9. Kaizer L, Warr D, Hoskins P, Latreille J, Lofters W, Yau J, Palmer M, Zee B, Levy M, Pater J: Effect of schedule and maintenance on the anticmetic efficacy of ondansetron combined with dexamethasone in acute and delayed emesis in patients receiving moderately emetogenic chemotherapy: A phase III trial by the National Cancer Institute of Canada Clinical Trials Group, J Clin Oncol 1994;12:1050-1057.
10. Aaronson NK, Ahmedzai S, Bergman B, Bul-lingcr M, Cull A, Duez N, Filiberti A, Flechtner H, Fleishman SB, deHacs JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Snecuw K, Sullivan M, Takeda F, for The European Organization for Research and Treatment of Cancer Study Group on Quality of Life: A quality-of-life instrument for use in international trials in oncology, J Natl Cancer Inst 1993:85:365-376.
11. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J: Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung canccr, Qual Life Res 1994;3:353-364.
12. Steel RGD, Torrie JH: Principles and Procedures of Statistics, ed 2, New York, McGraw-Hill, 1960.
13. Pater J, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J: Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting, Support Care Cancer 1994:2:161-166.
14. Latreille J, Stewart D, Laberge F, Hoskins P, Rushoven J, McMurtrie E, Warr D, Yelle L, Walde D, Shepherd F, et al: Dexamethasone improves the efficacy of granisetron in the first24 h following high-dose cisplatin chemotherapy, Support Care Cancer 1995:3:307-312.